| Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial S Sundar, PK Sinha, M Rai, DK Verma, K Nawin, S Alam, J Chakravarty, ... The Lancet 377 (9764), 477-486, 2011 | 379 | 2011 |
| Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan EAG Khalil, AME Hassan, EE Zijlstra, MM Mukhtar, HW Ghalib, B Musa, ... The lancet 356 (9241), 1565-1569, 2000 | 294 | 2000 |
| Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran I Sharifi, AR FeKri, MR Aflatonian, A Khamesipour, A Nadim, ... The Lancet 351 (9115), 1540-1543, 1998 | 289 | 1998 |
| Leishmaniasis vaccine candidates for development: a global overview A Khamesipour, S Rafati, N Davoudi, F Maboudi, F Modabber Indian Journal of Medical Research 123 (3), 423, 2006 | 270 | 2006 |
| Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis A Khamesipour, Y Dowlati, A Asilian, R Hashemi-Fesharki, A Javadi, ... Vaccine 23 (28), 3642-3648, 2005 | 258 | 2005 |
| First generation leishmaniasis vaccines: a review of field efficacy trials S Noazin, F Modabber, A Khamesipour, PG Smith, LH Moulton, K Nasseri, ... Vaccine 26 (52), 6759-6767, 2008 | 237 | 2008 |
| Handbook on isolation, characterization and cryopreservation of Leishmania DB Evans, D Godfrey, S Lanham, G Lanotte, F Modabber, L Schnur World Health Organization, 1989 | 201 | 1989 |
| A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran AZ Momeni, T Jalayer, M Emamjomeh, A Khamesipour, F Zicker, ... Vaccine 17 (5), 466-472, 1999 | 199 | 1999 |
| Vaccines against leishmaniasis F Modabber Annals of Tropical Medicine & Parasitology 89 (sup1), 83-88, 1995 | 198 | 1995 |
| Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation … RN Coler, YAW Skeiky, K Bernards, K Greeson, D Carter, CD Cornellison, ... Infection and immunity 70 (8), 4215-4225, 2002 | 181 | 2002 |
| Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis S Noazin, A Khamesipour, LH Moulton, M Tanner, K Nasseri, F Modabber, ... Vaccine 27 (35), 4747-4753, 2009 | 170 | 2009 |
| Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia ID Vélez, K Gilchrist, MP Arbelaez, CA Rojas, JA Puerta, CMF Antunes, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 99 (8 …, 2005 | 131 | 2005 |
| Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis P Olliaro, M Vaillant, B Arana, M Grogl, F Modabber, A Magill, O Lapujade, ... PLoS neglected tropical diseases 7 (3), e2130, 2013 | 129 | 2013 |
| A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis ER Mears, F Modabber, R Don, GE Johnson PLoS neglected tropical diseases 9 (9), e0003889, 2015 | 123 | 2015 |
| Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment AM Musa, EAG Khalil, FAE Mahgoub, SHH Elgawi, F Modabber, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (1 …, 2008 | 121 | 2008 |
| Increased myelopoiesis during Leishmania major infection in mice: generation of'safe targets', a possible way to evade the effector immune mechanism. AM Mirkovich, A Galelli, AC Allison, FZ Modabber Clinical and experimental immunology 64 (1), 1, 1986 | 118 | 1986 |
| Experiences with vaccines against cutaneous leishmaniasis: of men and mice F Modabber Parasitology 98 (S1), S49-S60, 1989 | 116 | 1989 |
| Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006 F Modabber, PA Buffet, E Torreele, G Milon, SL Croft Kinetoplastid Biology and Disease 6, 1-24, 2007 | 110 | 2007 |
| Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial J Machado‐Pinto, J Pinto, CA Da Costa, O Genaro, MJ Marques, ... International journal of dermatology 41 (2), 73-78, 2002 | 108 | 2002 |
| Vervet Monkeys Vaccinated with Killed Leishmania major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against … MM Gicheru, JO Olobo, CO Anjili, AS Orago, F Modabber, P Scott Infection and immunity 69 (1), 245-251, 2001 | 101 | 2001 |
